Nirsevimab Effectiveness Against Medically Attended Respiratory Syncytial Virus Illness and Hospitalization Among Alaska Native Children--Yukon-Kuskokwim Delta Region, Alaska, October 2023-June 2024

Authors :: Lefferts, Brian
Bressler, Sara
Keck, James W.
Desnoyers, Christine
Hodges, Ellen
January, Gerald
Morris, Kristina
Herrmann, Leslie
Singleton, Rosalyn
Aho, Sarah
Rogers, Julia
Newell, Katherine
Ohlsen, Elizabeth
Link-Gelles, Ruth
Dawood, Fatimah S.
Bruden, Dana
Fischer, Marc
Klejka, Joseph
Scobie, Heather M.
Source :: Morbidity and Mortality Weekly Report. November 14, 2024, Vol. 73 Issue 45, p1015, 7 p.
Publication Year :: 2024
Abstract: Introduction Respiratory syncytial virus (RSV) is a leading cause of hospitalization among young children (1). Historically, American Indian and Alaska Native (AI/AN) children have experienced high rates of RSV-associated hospitalization, [...]

Subjects :: Children -- Diseases
Palivizumab
Respiratory tract diseases
Infants
Native Americans
Virus diseases
Health

Tools